Catalyst Pharmaceuticals Inc at Citi Global Healthcare Conference Transcript
Today, it's my pleasure to be hosting Catalyst Pharmaceuticals for a fireside chat at Citi's Global Healthcare Conference. I'm joined today by CEO, Rich Daly; CFO, Mike Kalb; and Chief Commercial Officer, Jeff Del Carmen. Thank you so much for being here today, Rich, Mike and Steve.
Questions & Answers
To start, maybe, Rich, you could just like level set for us for those that might not be familiar that are listening in, can you just give us an overview of Catalyst and each of your product candidates?
Sam, thanks for the opportunity to be here. We really appreciate it. Happy to go over the products and be joined by my colleagues here and to talk about the scope and span of the business. So Catalyst -- the focus of Catalyst is orphan and rare diseases. We have 3 products.
We have FIRDAPSE,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
